Eltrombopag for use in children with immune thrombocytopenia.
Sign Up to like & getrecommendations! Published in 2018 at "Blood advances"
DOI: 10.1182/bloodadvances.2017010660
Abstract: Eltrombopag is currently the only US Food and Drug Administration-approved thrombopoietin receptor agonist for the treatment of chronic immune thrombocytopenia (ITP) in children. This oral, once-per-day therapy has shown favorable efficacy and adverse effect profiles… read more here.
Keywords: thrombocytopenia; eltrombopag use; immune thrombocytopenia; use children ... See more keywords
Editorial: Vaccination in children with immune-mediated diseases
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Pediatrics"
DOI: 10.3389/fped.2023.1192407
Abstract: COPYRIGHT © 2023 Toplak, Wulffraat and Uziel. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided… read more here.
Keywords: mediated diseases; children immune; vaccination children; immune mediated ... See more keywords